Build · Certara
Communicated clinical/economic value using BaseCase interactive apps (Abilify Maintena
Certara is a biosimulation software company (Simcyp, Phoenix) whose PK/PD and QSP models predict drug behavior in the body; the FDA itself licenses Certara's software to review sponsor submissions.
This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
Source
Published by Certara on its own site — read the original case study on certara.com ↗
More like this
Related use cases
- 01Cut QC time for regulatory submissions from hours to minutes using GlobalSubmit
- 02Shortened design-make-test-analyze discovery cycle using D360
- 03Enhanced pharmacokinetics workflows with a cloud-based PK solution
- 04Standardized real-world rare-disease data for FDA compliance
- 05Fast-tracked FDA approval of sunvozertinib for NSCLC via pharmacometrics
- 06PBPK modeling of Asciminib streamlined development, avoiding 10+ clinical studies